FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for treating skin inflammation and skin diseases in a subject. That is ensured by using formylpeptide receptor 2 (FPR2) agonist presented by general formula I or its pharmaceutically acceptable salt. Also disclosed is use for production of a pharmaceutical composition for treating skin inflammation and/or skin diseases.
EFFECT: group of inventions provides treating inflammation of skin or skin diseases by using formylpeptide receptor 2 (FPR2) agonists.
8 cl, 3 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF FORMYL PEPTIDE RECEPTOR 2 AGONISTS FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2768730C2 |
| USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
| IMIDAZOLE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS | 2015 |
|
RU2748652C2 |
| PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS | 2014 |
|
RU2703725C1 |
| AMIDE DERIVATIVES OF N-CARBAMIDE-SUBSTITUTED AMINO ACIDS AS MODULATORS OF FORMYLPEPTIDE RECEPTOR-1 (FPRL-1) | 2012 |
|
RU2744577C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| DEUTERATED BENZYL BENZENE DERIVATES AND METHODS FOR USE | 2009 |
|
RU2509773C2 |
| DERIVATIVES OF 2,5-DIOXOIMIDAZOLIDINE-1-YL-3-PHENYLUREA AS MODULATORS OF FORMYLPEEPTITIDE RECEPTOR 1 (FPRL-1) | 2012 |
|
RU2645673C2 |
| MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
| BUPRENORPHINE ANALOGUES | 2009 |
|
RU2520222C2 |
